WILLIAM L. TREACY, M.D.; ARCHIE H. BAGGENSTOSS, M.D.; CHARLES H. SLOCUMB, M.D.; CHARLES F. CODE, M.D.
Ehrman (1) in 1903 was the first to describe progressive dysphagia resulting from involvement of the esophagus in a case of scleroderma. In 1943, Lindsay, Templeton, and Rothman (2) described the roentgenographic changes of atony and apparent spasm of the cardia in scleroderma. Since then, hypomotility of the esophagus has become established as an early and quite characteristic change in scleroderma (3, 4).
This study was undertaken to explore the sclerodermatous process in the esophagus by correlating physiologic and pathologic changes. The investigation is divided into 3 parts:  a determination of the pathologic changes present in the esophagus in
TREACY WL, BAGGENSTOSS AH, SLOCUMB CH, CODE CF. Scleroderma of the Esophagus: A Correlation of Histologic and Physiologic Findings. Ann Intern Med. ;59:351–356. doi: 10.7326/0003-4819-59-3-351
Download citation file:
Published: Ann Intern Med. 1963;59(3):351-356.
Esophageal Disorders, Gastroenterology/Hepatology, Rheumatology, Scleroderma.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use